comprehensive -WSS

comprehensive

author：focus 2025-09-30 16:23:58 - browse：11626

Doctor holding a clipboard. -- health coverage from STAT — Adobe

The momentum around weight loss drugs is about to get even bigger in the wake of Novo Nordisk’s announcement that its semaglutide drug Wegovy cut the risk of cardiovascular disease by 20% in its large SELECT trial.

The full results of the study, funded by Novo, will be presented at the American Heart Association meeting in November. Doctors and researchers say they expect the findings to have a big impact on how clinicians approach the treatment of both obesity and cardiovascular disease, as well as increase the likelihood that prescriptions for obesity drugs will be covered by insurance.

But experts who spoke with STAT also cautioned that the long-term safety and efficacy of Wegovy and other weight loss drugs remain unknown. The SELECT study has yet to be peer-reviewed, and not enough information is yet available to make independent assessments of the results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

knowledge

WSS

Unmasking the 'centricity' illusion in clinical trials

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Who are the detained American citizens released from prison in Iran?

Unmasking the 'centricity' illusion in clinical trials

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

U.S. death rates show how politics are affecting public health

hotspot

comprehensive

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Louisiana bill approved classifying abortion pills as controlled substances

23andMe had bad news about my health. I wish a person had delivered it

Bird flu makes raw milk dangerous to consume, mouse study finds

Medical leaders decry Supreme Court decision on affirmative action

Listen: Your guide to Wegovy's blockbuster heart study

The cancer drug shortage isn’t new — and neither are the solutions

J&J reports mixed data on next

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

focus

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Unmasking the 'centricity' illusion in clinical trials

The world needs the new pandemic treaty

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Maui funeral service workers on devastation of fires: 'I'm in shock'

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

knowledge

leisure time

focus

focus